杨宁介入医学网

1. Smart control 支撑架的设计特点

 

2. Smart control 支撑架的应用

（1）髂动脉：

First Nitinol Iliac Stent Indicated for Primary Stenting of Common and External Iliac Arteries

（2）股浅动脉

（3）颈动脉：

         SMART Stents Look Promising in the Treatment of Cerebrovascular Disease

         Endovascular Stenting for Carotid Artery Stenosis: Preliminary Experience Using the Shape-memory–Alloy-recoverable–technology (SMART) Stent

（4）胆道：

Trust the S.M.A.R.T.^® Stent design.

Super-elastic nitinol

• Crush-recoverable
• Thermally self-expanding at body temperature
• Highly flexible before and after deployment

Micromesh design

• High radial resistive force*
• Superior strength
• Chronic outward force
• Minimal shortening

Delivery system

• Accurate placement and ease of use
• Treats range of lengths and diameters
• Atraumatic
• Available in 120mm and 150mm lengths.

（5）TIPS

（6）肾透析人工血管瘘狭窄

  Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis International Journal of Nephrology Volume 2011 (2011), Article ID 464735, 6 pages

  Comparison of SMART stent placement for arteriovenous graft salvage versus successful graft PTA.  J Vasc Interv Radiol. 2005 Dec;16(12):1619-26.

3. Smart control 支撑架应用结果

（1）荟萃分析：文献中没有查到有关smart stent 荟萃研究

（2）随机对照研究：

         A Study of the SMART Stent in the Treatment SFA Disease. (SIROCCO) （PPT课件）

        Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial.

        The Nitinol SMART stent vs Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results. Journal of Vascular and Interventional Radiology
Volume 15, Issue 9 , Pages 911-918, September 2004

      解读： Comparing the SMART stent with the Wallstent iliac endoprosthesis: reading between the lines.  J Vasc Interv Radiol. 2004 Sep;15(9):907-9.

       Sirolimus-Eluting Stents for the Treatment of Obstructive Superficial Femoral Artery Disease

       Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results.Circulation. 2002 Sep 17;106(12):1505-9.

       Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease: a randomized trial. Catheter Cardiovasc Interv. 2006 Feb;67(2):288-97.

（3）队列研究

（4）非随机对照研究：

        Multislice computed tomographic angiography versus digital subtraction angiography in the follow-up of nitinol stents in the superficial femoral artery.

（5）回顾性研究：

        Long-term results of the S.M.A.R.T. Control(TM) stent for superficial femoral artery lesions, J-SMART registry. Circ J. 2011;75(4):939-44. Epub 2011 Feb 11.

       Nakamura M. The door is open and the next step is forthcoming--lesson from J-SMART registry. Circ J. 2011;75(4):786-8. Epub 2011 Mar 5

（6）综述

（6）临床前研究：http://www.accessdata.fda.gov/cdrh_docs/pdf2/P020036b.pdf

（7）病例研究